Stockscreener 앱 받기
52.68
0.13%
0.07
시간 외 거래:
52.68
전일 마감가:
$52.61
열려 있는:
$52.67
하루 거래량:
4.68M
Relative Volume:
0.91
시가총액:
$6.08B
수익:
-
순이익/손실:
$-96.21M
주가수익비율:
-51.02
EPS:
-1.0326
순현금흐름:
$-82.18M
1주 성능:
+0.11%
1개월 성능:
+13.24%
6개월 성능:
+551.98%
1년 성능:
+2,181%
1일 변동 폭
$52.60
$52.69
1주일 범위
$52.55
$52.75
52주 변동 폭
$2.215
$53.19
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
52.68 | 6.07B | 0 | -96.21M | -82.18M | -1.0326 |
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2026-02-09 | 개시 | Leerink Partners | Outperform |
| 2025-11-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 개시 | Truist | Buy |
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-04 | 재개 | H.C. Wainwright | Neutral |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
Wall Street Recap: Is Terns Pharmaceuticals Inc a top pick in the sector2026 Trading Volume Trends & Weekly Stock Performance Updates - baoquankhu1.vn
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
TERN PE Ratio & Valuation, Is TERN Overvalued - Intellectia AI
TERN SEC FilingsTerns Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti Investigates Proposed Sale - National Today
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc.TERN - ChartMill
Merck’s Lower Terns Bid Highlights Oncology Ambition And Valuation Questions - Sahm
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? - Finviz
Merck nears $6 billion deal to buy Terns Pharma: Report - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasda - ChartMill
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition - CHEManager.
Merck begins tender offer to buy Terns Pharmaceuticals - MSN
TERN Stock Price, Quote & Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Merck & Co Inc Stock (MRK) Moved Up by 3.18% on Apr 8: Facts Behind the Movement - TradingKey
$680 Million in Daily Turnover Crowns Terns as Most Active Stock Ahead of Merck Deal - Bitget
How Merck slashed its bid for Terns Pharmaceuticals by $1B after reviewing cancer drug trial data - The Business Journals
Why Terns Pharmaceuticals Stock Rocked the Market in March - The Globe and Mail
Mizuho reiterates Terns Pharmaceuticals stock rating at Neutral By Investing.com - Investing.com Canada
Terns’ drug may not be as competitive as many initially thought - statnews.com
Leerink Partners Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating - Moomoo
Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals - Indian Pharma Post
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review - Sahm
Merck’s US$6.7b Terns Deal And What It Means For Valuation - Sahm
Merck’s (NYSE:MRK) Terns Deal And S&P 500 Valuation Impact Explained - Kalkine Media
William Blair Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Announces Target Price $53 - Moomoo
William Blair downgrades Terns Pharmaceuticals stock rating on Merck deal By Investing.com - Investing.com Canada
Merck To Acquire Terns Pharmaceuticals - citybiz
What's Going On With Merck Stock Tuesday? - Benzinga
Terns rebuffed a higher bid before selling to Merck - BioPharma Dive
Merck (MRK) Initiates Tender Offer for Terns Pharmaceuticals - GuruFocus
Merck begins tender offer to buy Terns Pharmaceuticals (MRK:NYSE) - Seeking Alpha
Merck begins tender offer to acquire Terns Pharmaceuticals, Inc. - marketscreener.com
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share - StreetInsider
Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc. - TradingView
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Bluefield Daily Telegraph
[SC 14D9] Terns Pharmaceuticals, Inc. Tender Offer Recommendation - Stock Titan
Merck (NYSE: TERN) to acquire Terns for $53.00 per share cash - Stock Titan
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a ... - Bluefield Daily Telegraph
Shareholder Alert: Ademi LLP investigates whether Terns - GlobeNewswire
Merck nears deal to buy Terns Pharmaceuticals - MSN
Merck to buy Terns for $6.7 billion to grow in blood cancers - MSN
43,857 Shares in Terns Pharmaceuticals, Inc. $TERN Acquired by SG Americas Securities LLC - MarketBeat
Capricorn Fund Managers Ltd Takes $6.12 Million Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
TERN Technical Analysis | Trend, Signals & Chart Patterns | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Aug Mood: Can Terns Pharmaceuticals Inc be the next market leaderGap Up & Real-Time Stock Entry Alerts - baoquankhu1.vn
Barclays downgrades Terns Pharmaceuticals (TERN) - MSN
Terns Pharmaceuticals Grants Inducement Shares to New Employees - National Today
Emil Kuriakose Sells 942 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat
Terns Pharmaceuticals (TERN) CMO sells shares to cover RSU taxes - Stock Titan
Press Release: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - Moomoo
Merck's $6.7 billion Terns Pharmaceuticals acquisition may face rival interest: Analyst - MSN
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.81%
자본화:
|
볼륨(24시간):